Ignite Creation Date:
2025-12-25 @ 12:36 AM
Ignite Modification Date:
2026-01-02 @ 12:06 PM
Study NCT ID:
NCT04735367
Status:
COMPLETED
Last Update Posted:
2025-12-09
First Post:
2021-01-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Evaluate Overall Survival in Japanese Patients With HR+/HER2- Advanced Breast Cancer Treated With Palbociclib Plus Letrozole
Sponsor:
Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-02-03
Start Date Type:
ACTUAL
Primary Completion Date:
2023-09-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-09-29
Completion Date Type:
ACTUAL
First Submit Date:
2021-01-28
First Submit QC Date:
None
Study First Post Date:
2021-02-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-09-26
Results First Submit QC Date:
None
Results First Post Date:
2025-12-09
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-22
Last Update Post Date:
2025-12-09
Last Update Post Date Type:
ESTIMATED